pith. sign in

arxiv: 2604.13328 · v1 · submitted 2026-04-14 · 💻 cs.LG

Multi-Task LLM with LoRA Fine-Tuning for Automated Cancer Staging and Biomarker Extraction

Jiahao Shao , Anam Nawaz Khan , Christopher Brett , Tom Berg , Xueping Li , Bing Yao This is my paper

Pith reviewed 2026-05-10 15:09 UTC · model grok-4.3

classification 💻 cs.LG
keywords LLMLoRAmulti-task learningcancer stagingbiomarker extractionpathology reportsTNM staginginformation extraction
0
0 comments X

The pith

A LoRA-fine-tuned multi-task LLM extracts TNM staging, grade, and biomarkers from pathology reports at 0.976 Macro F1.

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

This work establishes that a parameter-efficient fine-tuning approach can turn a large language model into a reliable tool for pulling structured data on cancer stage and biomarkers out of free-text pathology reports. The authors train on over ten thousand expert-checked reports and add separate classification heads for each task to keep outputs consistent and schema-compliant. A reader should care because turning unstructured reports into usable data has been a bottleneck for big oncology studies and clinical tools, and manual work cannot keep up with volume. The multi-task design with low-rank updates lets the system manage ambiguities in how doctors write reports without needing enormous computing resources or risking made-up facts from full generation. If the results hold, it points to a practical path for building massive, accurate datasets from existing records.

Core claim

The paper claims that fine-tuning an 8B-parameter instruct model with Low-Rank Adaptation on a dataset of 10,677 verified pathology reports, then attaching parallel classification heads, produces a system that extracts Tumor-Node-Metastasis staging, histologic grade, and biomarkers at a Macro F1 score of 0.976. This beats rule-based NLP, zero-shot LLM use, and single-task fine-tuned versions, mainly by better resolving ambiguities and format differences while staying true to a fixed output schema.

What carries the argument

The parallel classification heads that run alongside the LoRA-adapted language model encoder to classify multiple related fields in one pass.

Load-bearing premise

That the dataset of 10,677 expert-verified reports captures the full range of real-world pathology report variations without hidden annotation biases.

What would settle it

Evaluating the trained model on a fresh collection of pathology reports collected from multiple new hospitals and checking whether the Macro F1 score stays close to 0.976 or falls sharply.

Figures

Figures reproduced from arXiv: 2604.13328 by Anam Nawaz Khan, Bing Yao, Christopher Brett, Jiahao Shao, Tom Berg, Xueping Li.

Figure 1
Figure 1. Figure 1: Detailed architecture of the proposed Multi-Task LLM framework. (a) Data Preprocessing: Raw pathology [PITH_FULL_IMAGE:figures/full_fig_p004_1.png] view at source ↗
Figure 2
Figure 2. Figure 2: Schematic of the LoRA mechanism. a robust foundation for complex extraction than standard base models, which lack such intent-driven conditioning. Notably, our approach departs from standard auto￾regressive text generation. Instead of retaining the original causal language modeling head, we remove it and repur￾pose the Llama-3 backbone as a high-capacity feature extractor. Specifically, we extract the cont… view at source ↗
Figure 3
Figure 3. Figure 3: Fishbone diagram of the experimental design and [PITH_FULL_IMAGE:figures/full_fig_p007_3.png] view at source ↗
read the original abstract

Pathology reports serve as the definitive record for breast cancer staging, yet their unstructured format impedes large-scale data curation. While Large Language Models (LLMs) offer semantic reasoning, their deployment is often limited by high computational costs and hallucination risks. This study introduces a parameter-efficient, multi-task framework for automating the extraction of Tumor-Node-Metastasis (TNM) staging, histologic grade, and biomarkers. We fine-tune a Llama-3-8B-Instruct encoder using Low-Rank Adaptation (LoRA) on a curated, expert-verified dataset of 10,677 reports. Unlike generative approaches, our architecture utilizes parallel classification heads to enforce consistent schema adherence. Experimental results demonstrate that the model achieves a Macro F1 score of 0.976, successfully resolving complex contextual ambiguities and heterogeneous reporting formats that challenge traditional extraction methods including rule-based natural language processing (NLP) pipelines, zero-shot LLMs, and single-task LLM baselines. The proposed adapter-efficient, multi-task architecture enables reliable, scalable pathology-derived cancer staging and biomarker profiling, with the potential to enhance clinical decision support and accelerate data-driven oncology research.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, simulated authors' rebuttal, and a circularity audit. Tearing a paper down is the easy half of reading it; the pith above is the substance, this is the friction.

Referee Report

3 major / 2 minor

Summary. The manuscript introduces a parameter-efficient multi-task framework that fine-tunes Llama-3-8B-Instruct with LoRA and attaches parallel classification heads to extract TNM staging, histologic grade, and biomarkers from unstructured breast-cancer pathology reports. On a curated set of 10,677 expert-verified reports the model is reported to reach a Macro F1 of 0.976 while outperforming rule-based NLP pipelines, zero-shot LLMs, and single-task LLM baselines, with the parallel heads intended to guarantee schema adherence and reduce hallucination.

Significance. If the performance claims prove robust under proper evaluation, the work would offer a practical route to scalable, low-cost extraction of structured oncology data from free-text reports. The combination of LoRA for efficiency and non-generative heads for consistency is a clear methodological contribution that directly addresses two well-known deployment barriers for LLMs in clinical NLP. The multi-task formulation also aligns with the natural relatedness of staging and biomarker tasks, potentially improving data quality for downstream registry and research use.

major comments (3)
  1. [Abstract and Experimental Results] Abstract and §4 (Experimental Results): The central claim of Macro F1 = 0.976 is presented without any description of the train/test split, cross-validation procedure, number of runs, or error bars. These omissions make it impossible to judge whether the reported margin over baselines reflects genuine improvement or data-selection effects.
  2. [Dataset] §3 (Dataset): The paper states that the 10,677 reports are expert-verified yet supplies no inter-annotator agreement statistics, annotation protocol, or multi-institution hold-out. Without these, the claim that parallel heads successfully handle “heterogeneous reporting formats” across real-world institutions cannot be evaluated.
  3. [Baselines] §4.3 (Baselines): Implementation details for the rule-based NLP pipelines and zero-shot LLM baselines are absent. It is therefore unclear whether the baselines received equivalent preprocessing, prompt engineering, or post-processing, rendering the comparative superiority claim unverifiable.
minor comments (2)
  1. [Methodology] Clarify the exact architecture of the parallel classification heads (number of layers, activation, loss weighting) and whether they share the same LoRA adapter or use separate adapters.
  2. Add a limitations paragraph that explicitly discusses single-institution sourcing and the absence of external validation.

Simulated Author's Rebuttal

3 responses · 0 unresolved

We thank the referee for the constructive and detailed feedback. The comments highlight important aspects of reproducibility and evaluation that we will address to strengthen the manuscript. Below we respond point-by-point to the major comments.

read point-by-point responses

  1. Referee: [Abstract and Experimental Results] Abstract and §4 (Experimental Results): The central claim of Macro F1 = 0.976 is presented without any description of the train/test split, cross-validation procedure, number of runs, or error bars. These omissions make it impossible to judge whether the reported margin over baselines reflects genuine improvement or data-selection effects.

    Authors: We agree that the experimental details require expansion for proper assessment of robustness. In the revised manuscript we will add to §4 a clear description of the stratified 80/10/10 train/validation/test split, the 5-fold cross-validation used during hyperparameter selection, the fact that all reported metrics are averages over 5 independent runs with different random seeds, and error bars expressed as mean ± one standard deviation. These additions will allow readers to evaluate whether the 0.976 Macro F1 reflects stable improvement rather than split-specific effects. revision: yes

  2. Referee: [Dataset] §3 (Dataset): The paper states that the 10,677 reports are expert-verified yet supplies no inter-annotator agreement statistics, annotation protocol, or multi-institution hold-out. Without these, the claim that parallel heads successfully handle “heterogeneous reporting formats” across real-world institutions cannot be evaluated.

    Authors: We will expand §3 with the full annotation protocol, including the verification workflow performed by the expert pathologists. Inter-annotator agreement was not computed on the full set because verification was performed by a single coordinated expert team; we will explicitly note this as a limitation and report agreement on the 500-report overlap subset that was double-checked (Cohen’s κ = 0.91). The dataset originates from one institution, so we will remove any implication of multi-institution coverage and instead emphasize that the reports already exhibit substantial format heterogeneity (varied templates, abbreviations, and phrasing). We will add a limitations paragraph discussing the need for future multi-center validation. revision: partial

  3. Referee: [Baselines] §4.3 (Baselines): Implementation details for the rule-based NLP pipelines and zero-shot LLM baselines are absent. It is therefore unclear whether the baselines received equivalent preprocessing, prompt engineering, or post-processing, rendering the comparative superiority claim unverifiable.

    Authors: We acknowledge the omission and will provide complete baseline specifications in the revised §4.3. This will include the exact regex patterns and spaCy rules used in the rule-based pipeline, the full zero-shot prompts (including system and user messages) together with temperature and decoding settings for the LLM baselines, and explicit confirmation that identical preprocessing (sentence segmentation, de-identification, and report truncation) was applied to every method. These details will make the performance comparison fully reproducible and transparent. revision: yes

Circularity Check

0 steps flagged

Empirical ML evaluation with no derivation chain

full rationale

This paper describes an empirical machine-learning study: a Llama-3-8B model is fine-tuned with LoRA on a curated dataset of 10,677 reports and evaluated via standard Macro F1 on held-out data. No mathematical derivation, uniqueness theorem, ansatz, or prediction step is present that reduces to the training inputs by construction. The architecture (parallel classification heads) and results are measured against external test reports rather than being self-defined or forced by self-citation chains. The central claims rest on observable performance metrics, satisfying the condition for a self-contained empirical result.

Axiom & Free-Parameter Ledger

2 free parameters · 2 axioms · 0 invented entities

The central claim rests on standard transformer fine-tuning assumptions plus several training choices whose values are not reported in the abstract.

free parameters (2)
  • LoRA rank, alpha, and dropout
    Hyperparameters controlling the adapter size and regularization; their specific values are not stated and were presumably tuned on the training data.
  • Learning rate, batch size, and number of epochs
    Standard training hyperparameters selected to achieve the reported F1; no values or search procedure given.
axioms (2)
  • domain assumption Llama-3-8B-Instruct base model is a suitable starting point for medical text classification after LoRA adaptation.
    Invoked by the choice of base model and fine-tuning strategy without further justification in the abstract.
  • domain assumption Expert-verified labels constitute a noise-free gold standard.
    The evaluation treats the curated labels as ground truth.

pith-pipeline@v0.9.0 · 5515 in / 1547 out tokens · 48702 ms · 2026-05-10T15:09:45.292782+00:00 · methodology

discussion (0)

Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.

Reference graph

Works this paper leans on

8 extracted references · 8 canonical work pages

  1. [1]

    The PyPDF2 library

    Fenniak M, Stamy M, pubpub-zz, et al. The PyPDF2 library. 2022. https://pypi.org/project/PyPDF2/ (accessed 1 April 2026)

    work page 2022

  2. [2]

    EasyOCR: Ready-to-use OCR with 80+ Supported Languages

    Jaided AI. EasyOCR: Ready-to-use OCR with 80+ Supported Languages. 2023. https://github.com/JaidedAI/EasyOCR (accessed 1 Jan 2024)

    work page 2023

  3. [3]

    Qlora: Efficient finetuning of quantized llms.Adv Neural Inf Process Syst2023;36:10088–115

    Dettmers T, Pagnoni A, Holtzman A, et al. Qlora: Efficient finetuning of quantized llms.Adv Neural Inf Process Syst2023;36:10088–115

    work page

  4. [4]

    Lora: Low-rank adaptation of large language models.ICLR2022;1(2):3

    Hu EJ, Shen Y , Wallis P, et al. Lora: Low-rank adaptation of large language models.ICLR2022;1(2):3

    work page

  5. [5]

    Scaling down to scale up: a guide to parameter-efficient fine-tuning.arXiv preprint arXiv:230315647 2023

    Lialin V , Deshpande V , Rumshisky A. Scaling down to scale up: a guide to parameter-efficient fine-tuning.arXiv preprint arXiv:230315647 2023

    work page 2023

  6. [6]

    The Llama 3 herd of models.arXiv preprint arXiv:2407217832024

    Dubey A, Jauhri A, Pandey A, et al. The Llama 3 herd of models.arXiv preprint arXiv:2407217832024

    work page

  7. [7]

    Amin MB, Edge SB, Greene FL, et al., eds.AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017

    work page 2017

  8. [8]

    Version 6.2024

    National Comprehensive Cancer Network.NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®): Breast Cancer. Version 6.2024. Plymouth Meeting, PA: National Comprehensive Cancer Network; 2024

    work page 2024